menu search

IPSEY / Ipsen S.A.'s (IPSEY) CEO David Loew on Q2 2022 Results - Earnings Call Transcript

Ipsen S.A.'s (IPSEY) CEO David Loew on Q2 2022 Results - Earnings Call Transcript
Ipsen S.A. (OTCPK:IPSEY) Q2 2022 Earnings Conference Call July 28, 2022 7:30 AM ET Company Participants David Loew – Chief Executive Officer Aymeric Le Chatelier – Chief Financial Officer Howard Mayer – Head of Research and Development Conference Call Participants Michael Leuchten – UBS Keyur Parekh – Goldman Sachs Thibault Boutherin – Morgan Stanley Elizabeth Walton – Credit Suisse Simon Baker – Redburn Delphine Le Louët – Societe Generale Richard Vosser – J.P. Morgan Sachin Jain – Bank of America Operator Good day, everyone, and welcome to the Ipsen's H1 2022 Results Conference Call. Read More
Posted: Jul 30 2022, 06:07
Author Name: Seeking Alpha
Views: 101816

IPSEY News  

US FDA approves Ipsen's rare bone disorder drug

By Reuters
August 16, 2023

US FDA approves Ipsen's rare bone disorder drug

The U.S. Food and Drug Administration on Wednesday approved French drugmaker Ipsen's bone disorder drug, making it the first treatment available to pa more_horizontal

Ipsen S.A. (IPSEY) Q4 2022 Earnings Call Transcript

By Seeking Alpha
February 9, 2023

Ipsen S.A. (IPSEY) Q4 2022 Earnings Call Transcript

Ipsen S.A. (OTCPK:IPSEY) Q4 2022 Results Conference Call February 9, 2023 7:45 AM ET Company Participants David Loew - CEO Aymeric Le Chatelier - CFO more_horizontal

Ipsen S.A.'s (IPSEY) CEO David Loew on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
July 30, 2022

Ipsen S.A.'s (IPSEY) CEO David Loew on Q2 2022 Results - Earnings Call Transcript

Ipsen S.A. (OTCPK:IPSEY) Q2 2022 Earnings Conference Call July 28, 2022 7:30 AM ET Company Participants David Loew – Chief Executive Officer Aymeric more_horizontal


Search within

Pages Search Results: